Repository logo
 
Publication

In vitro evaluation of peptides with potential antioxidant, anti-inflammatory and antihypertensive activities

dc.contributor.authorBorges, Thais
dc.contributor.authorFerraz, Ricardo
dc.contributor.authorCoelho, Pedro
dc.contributor.authorPrudêncio, Cristina
dc.contributor.authorGomes, Ana
dc.contributor.authorGomes, Paula
dc.date.accessioned2024-05-23T13:39:52Z
dc.date.available2024-05-23T13:39:52Z
dc.date.issued2023-05
dc.description.abstractHypertension develops from genetic and environmental factors, and is exacerbated by disorders that increase systemic vascular resistance, like oxidative stress, inflammation and immune system dysfunction1,2. The search for natural compounds as an alternative or a complement to the drugs used to treat hypertension and other chronic diseases has gained momentum in recent years1 . One example is that of food-derived peptides as nutraceuticals3,4,5. In this context, we are exploring the antioxidant, anti-inflammatory, and antihypertensive potential of synthetic peptides derived from proteins found in milk (lactoferrins from different species of mammals) and in other food sources (e.g., jumbo squid - Dosidicus gigas). Antioxidant activity in vitro was determined by both the DPPH radical scavenging activity and the Ferric Reducing Antioxidant Power (FRAP) assays. While none of the squid peptides was active, lactoferrin (LF) ones showed antioxidant potential: aLF-17-31, from donkey (Equus africanus asinus) LF, displayed the stronger radical scavenging activity (IC50 3.53 mol/mol DPPH), and nhLF268-284, from human (Homo sapiens) LF, showed the stronger reducing power (1.26 ± 0.86 mM Fe2+ equivalents). The ABTS radical scavenging activity of LF peptides was further assessed, with bLF-1-11 from bovine (Bos taurus) LF standing out with a Total Antioxidant Status (TAS) of 5.68 ± 9.23 mM. The peptides’ ability to inhibit the angiotensin converting enzyme 1 (ACE1) was also tested in vitro, as an indication of their antihypertensive potential; squid peptide RC7 inhibited ACE1 with an IC50 of 908.6 µM. Relevantly, none of the peptides was cytotoxic (MTT assay on macrophages), as only bLF1-11 showed some toxicity (IC50 417.6 µg/mL). In conclusion, new non-toxic food-derived peptides with ntioxidant/antihypertensive activity were found. Ongoing studies will assess their anti-inflammatory activity (Griess method) as well as their effect of on the TAS in macrophages (superoxide anion production).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBorges, T., Ferraz, R., Coelho, P., Prudêncio, C., Gomes, A., & Gomes, P. (2023). In vitro evaluation of peptides with potential antioxidant, anti-inflammatory and antihypertensive activities. Livro de Resumos do 16º Encontro de Investigação Jovem da U.Porto, 598–599.pt_PT
dc.identifier.isbn978-989-746-356-3
dc.identifier.urihttp://hdl.handle.net/10400.22/25550
dc.language.isoengpt_PT
dc.publisherUniversidade do Portopt_PT
dc.relationThe authors thank Fundação para a Ciência e Tecnologia, I.P. (FCT) for funding this research through project NANOPROMILK (PTDC/BAA-AGR/4923/2021). Thanks are further due to FCT for financial support to the LAQV-REQUIMTE research unit (UIDB/50006/2020).pt_PT
dc.relation.publisherversionhttps://www.up.pt/ijup/wp-content/uploads/sites/892/2023/06/Livro-de-Resumos_final.pdfpt_PT
dc.subjectHypertensionpt_PT
dc.subjectNutraceuticalspt_PT
dc.subjectBioactive peptidespt_PT
dc.subjectAntioxidantpt_PT
dc.subjectAnti-inflammatorypt_PT
dc.subjectAntihypertensivept_PT
dc.titleIn vitro evaluation of peptides with potential antioxidant, anti-inflammatory and antihypertensive activitiespt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlacePortopt_PT
oaire.citation.endPage599pt_PT
oaire.citation.issue16ªpt_PT
oaire.citation.startPage598pt_PT
oaire.citation.titleLivro de Resumos do 16º Encontro de Investigação Jovem da U.Portopt_PT
person.familyNameFerraz
person.familyNameCoelho
person.familyNamePrudêncio
person.givenNameRicardo
person.givenNamePedro
person.givenNameCristina
person.identifier1200571
person.identifier.ciencia-id001E-71CE-F92D
person.identifier.ciencia-idBE18-3DB2-8D79
person.identifier.ciencia-idC81E-F4EE-FADE
person.identifier.orcid0000-0002-1761-117X
person.identifier.orcid0000-0002-2343-1108
person.identifier.orcid0000-0002-9920-936X
person.identifier.ridG-5639-2011
person.identifier.ridAAZ-9239-2020
person.identifier.scopus-author-id24464208500
person.identifier.scopus-author-id57214054449
person.identifier.scopus-author-id6508057930
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublicationa5a8faa7-12a5-4b1c-bced-44c895677397
relation.isAuthorOfPublicationeb030614-4140-437b-8ac3-f59c52566ecf
relation.isAuthorOfPublication881a8ad5-ab13-4e49-89f4-08ca61cc81e3
relation.isAuthorOfPublication.latestForDiscoverya5a8faa7-12a5-4b1c-bced-44c895677397

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
POSTER_Ricardo Ferraz.pdf
Size:
281.16 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: